Mr Paul D Koerner, MD | |
1290 Kelley Drive, Paris, TN 38242 | |
(731) 664-3522 | |
(901) 922-6767 |
Full Name | Mr Paul D Koerner |
---|---|
Gender | Male |
Speciality | Radiation Oncology |
Experience | 30 Years |
Location | 1290 Kelley Drive, Paris, Tennessee |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023072485 | NPI | - | NPPES |
3702343 | Medicaid | TN | |
3720631 | Medicaid | TN | |
3720567 | Medicaid | TN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0001X | Radiology - Radiation Oncology | MD31746 (Tennessee) | Primary |
Entity Name | The West Clinic, Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1447276605 PECOS PAC ID: 2668360579 Enrollment ID: O20040315000610 |
News Archive
DUSA Pharmaceuticals, Inc.®, a dermatology company that is developing and marketing Levulan® Photodynamic Therapy (PDT), today announced that the United States Patent and Trademark Office has issued a notice of allowance for a key patent related to its proprietary PDT light source, the BLU-U®, Blue Light Photodynamic Therapy Illuminator.
Given Imaging Ltd., the global leader in capsule endoscopy, today announced the launch of its second-generation PillCam® COLON capsule at the Gastro 2009 Conference taking place in London. Like Given Imaging's other capsule endoscopes, PillCam® SB and PillCam® ESO, PillCam COLON could be a more patient-friendly tool for imaging the gastrointestinal tract.
Team work is just as important in your brain as it is on the playing field: A new study published online on April 19 by the Proceedings of the National Academy of Sciences reports that groups of brain cells can substantially improve their ability to discriminate between different orientations of simple visual patterns by synchronizing their electrical activity.
New research presented at the Society for Endocrinology annual conference in Brighton appears to identify novel methods of therapy for an aggressive type of breast cancer as well as uncovering potential causative factors. The focus of the study is to show how common chemicals present in our surroundings are possibly putting women at risk of a type of breast cancer called triple negative breast cancer (TNBC).
A study led by researchers at the University of North Carolina indicates that a newly approved blood thinner that blocks a key component of the human blood clotting system may increase the risk and severity of certain viral infections, including flu and myocarditis, a viral infection of the heart and a significant cause of sudden death in children and young adults.
› Verified 5 days ago
Entity Name | Radiation Oncology Associates, Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1043380108 PECOS PAC ID: 6709896558 Enrollment ID: O20060425000338 |
News Archive
DUSA Pharmaceuticals, Inc.®, a dermatology company that is developing and marketing Levulan® Photodynamic Therapy (PDT), today announced that the United States Patent and Trademark Office has issued a notice of allowance for a key patent related to its proprietary PDT light source, the BLU-U®, Blue Light Photodynamic Therapy Illuminator.
Given Imaging Ltd., the global leader in capsule endoscopy, today announced the launch of its second-generation PillCam® COLON capsule at the Gastro 2009 Conference taking place in London. Like Given Imaging's other capsule endoscopes, PillCam® SB and PillCam® ESO, PillCam COLON could be a more patient-friendly tool for imaging the gastrointestinal tract.
Team work is just as important in your brain as it is on the playing field: A new study published online on April 19 by the Proceedings of the National Academy of Sciences reports that groups of brain cells can substantially improve their ability to discriminate between different orientations of simple visual patterns by synchronizing their electrical activity.
New research presented at the Society for Endocrinology annual conference in Brighton appears to identify novel methods of therapy for an aggressive type of breast cancer as well as uncovering potential causative factors. The focus of the study is to show how common chemicals present in our surroundings are possibly putting women at risk of a type of breast cancer called triple negative breast cancer (TNBC).
A study led by researchers at the University of North Carolina indicates that a newly approved blood thinner that blocks a key component of the human blood clotting system may increase the risk and severity of certain viral infections, including flu and myocarditis, a viral infection of the heart and a significant cause of sudden death in children and young adults.
› Verified 5 days ago
Entity Name | Cancer Care Center Of Henry County Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1275650434 PECOS PAC ID: 1658558465 Enrollment ID: O20110603000314 |
News Archive
DUSA Pharmaceuticals, Inc.®, a dermatology company that is developing and marketing Levulan® Photodynamic Therapy (PDT), today announced that the United States Patent and Trademark Office has issued a notice of allowance for a key patent related to its proprietary PDT light source, the BLU-U®, Blue Light Photodynamic Therapy Illuminator.
Given Imaging Ltd., the global leader in capsule endoscopy, today announced the launch of its second-generation PillCam® COLON capsule at the Gastro 2009 Conference taking place in London. Like Given Imaging's other capsule endoscopes, PillCam® SB and PillCam® ESO, PillCam COLON could be a more patient-friendly tool for imaging the gastrointestinal tract.
Team work is just as important in your brain as it is on the playing field: A new study published online on April 19 by the Proceedings of the National Academy of Sciences reports that groups of brain cells can substantially improve their ability to discriminate between different orientations of simple visual patterns by synchronizing their electrical activity.
New research presented at the Society for Endocrinology annual conference in Brighton appears to identify novel methods of therapy for an aggressive type of breast cancer as well as uncovering potential causative factors. The focus of the study is to show how common chemicals present in our surroundings are possibly putting women at risk of a type of breast cancer called triple negative breast cancer (TNBC).
A study led by researchers at the University of North Carolina indicates that a newly approved blood thinner that blocks a key component of the human blood clotting system may increase the risk and severity of certain viral infections, including flu and myocarditis, a viral infection of the heart and a significant cause of sudden death in children and young adults.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Mr Paul D Koerner, MD 1290 Kelley Drive, Paris, TN 38242 Ph: (731) 664-3522 | Mr Paul D Koerner, MD 1290 Kelley Drive, Paris, TN 38242 Ph: (731) 664-3522 |
News Archive
DUSA Pharmaceuticals, Inc.®, a dermatology company that is developing and marketing Levulan® Photodynamic Therapy (PDT), today announced that the United States Patent and Trademark Office has issued a notice of allowance for a key patent related to its proprietary PDT light source, the BLU-U®, Blue Light Photodynamic Therapy Illuminator.
Given Imaging Ltd., the global leader in capsule endoscopy, today announced the launch of its second-generation PillCam® COLON capsule at the Gastro 2009 Conference taking place in London. Like Given Imaging's other capsule endoscopes, PillCam® SB and PillCam® ESO, PillCam COLON could be a more patient-friendly tool for imaging the gastrointestinal tract.
Team work is just as important in your brain as it is on the playing field: A new study published online on April 19 by the Proceedings of the National Academy of Sciences reports that groups of brain cells can substantially improve their ability to discriminate between different orientations of simple visual patterns by synchronizing their electrical activity.
New research presented at the Society for Endocrinology annual conference in Brighton appears to identify novel methods of therapy for an aggressive type of breast cancer as well as uncovering potential causative factors. The focus of the study is to show how common chemicals present in our surroundings are possibly putting women at risk of a type of breast cancer called triple negative breast cancer (TNBC).
A study led by researchers at the University of North Carolina indicates that a newly approved blood thinner that blocks a key component of the human blood clotting system may increase the risk and severity of certain viral infections, including flu and myocarditis, a viral infection of the heart and a significant cause of sudden death in children and young adults.
› Verified 5 days ago
Stephen Robert Mitchell, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 300 Hospital Drive, Paris, TN 38242 Phone: 615-444-2320 Fax: 615-449-3163 | |
Dr. Ina Radtke, M.D. PH.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 300 Hospital Cir, Suite 1031, Paris, TN 38242 Phone: 731-642-1220 | |
Dr. Ian R Graham, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: Henry County Medical Center, 301 Tyson Avenue, Paris, TN 38424 Phone: 731-644-8535 Fax: 731-642-9588 | |
Dr. Graham Lee Roberts, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 301 Tyson Ave, Paris, TN 38242 Phone: 731-644-8379 Fax: 731-644-8488 |